Article
Differential modulation of the androgen receptor for prostate cancer therapy depends on the DNA response element
16 Mar 2020
Abstract excerpt
Androgen receptor (AR) action is a hallmark of prostate cancer (PCa) with androgen deprivation being standard therapy. Yet, resistance arises and aberrant AR signaling promotes disease. We sought compounds that inhibited genes driving cancer but not normal growth and hypothesized that genes with consensus androgen response elements (cAREs) drive proliferation but genes with selective elements (sAREs) promote...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
